본문 바로가기
KERD
논문KCI 등재

Paranasal Sinus Invasion in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose The aim of this study is to evaluate the prognostic significance of paranasal sinus invasion for nasopharyngeal carcinoma (NPC) and its suitable position in the T classification. Materials and Methods The magnetic resonance imaging (MRI) scans of 695 patients with previously untreated, biopsy-proven, non-metastatic NPC that was treated with intensity-modulated radiotherapy (IMRT) were reviewed retrospectively. Results The incidence of paranasal sinus invasion was 39.4% (274 of 695 patients). Multivariate analysis showed that paranasal sinus invasion was an independent negative prognostic factor for local failure-free survival (LFFS) (p < 0.05). According to the eighth American Joint Committee on Cancer (AJCC) staging system, 275 patients were classified as T3 classification. Of these, 78 patients (28.4%) developed paranasal sinus invasion (T3b) and 197 (71.6%) didn’t (T3a). The estimated 5-year LFFS and overall survival (OS) rates for the patients with T3b and T3a classification were 88.6% versus 95.0% (p=0.047), and 84.5% versus 93.3% (p=0.183), respectively. The estimated 5-year LFFS and OS rates for the patients with T4 classification were 89.5% and 83.2%, which were similar with the outcomes of patients with T3b classification. Conclusion MRI-determined paranasal sinus invasion is an independent prognostic factor of NPC treated by IMRT. Paranasal sinus invasion is recommended to classify as T4 classification in the 8th AJCC staging system for NPC.

Abstract

Purpose The aim of this study is to evaluate the prognostic significance of paranasal sinus invasion for nasopharyngeal carcinoma (NPC) and its suitable position in the T classification. Materials and Methods The magnetic resonance imaging (MRI) scans of 695 patients with previously untreated, biopsy-proven, non-metastatic NPC that was treated with intensity-modulated radiotherapy (IMRT) were reviewed retrospectively. Results The incidence of paranasal sinus invasion was 39.4% (274 of 695 patients). Multivariate analysis showed that paranasal sinus invasion was an independent negative prognostic factor for local failure-free survival (LFFS) (p < 0.05). According to the eighth American Joint Committee on Cancer (AJCC) staging system, 275 patients were classified as T3 classification. Of these, 78 patients (28.4%) developed paranasal sinus invasion (T3b) and 197 (71.6%) didn’t (T3a). The estimated 5-year LFFS and overall survival (OS) rates for the patients with T3b and T3a classification were 88.6% versus 95.0% (p=0.047), and 84.5% versus 93.3% (p=0.183), respectively. The estimated 5-year LFFS and OS rates for the patients with T4 classification were 89.5% and 83.2%, which were similar with the outcomes of patients with T3b classification. Conclusion MRI-determined paranasal sinus invasion is an independent prognostic factor of NPC treated by IMRT. Paranasal sinus invasion is recommended to classify as T4 classification in the 8th AJCC staging system for NPC.

참고문헌 (20)

  1. International Agency for Research on Cancer, "GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012" (2012), IARC Press
  2. Amin MB, "AJCC cancer staging manual" (2017), Springer
  3. Pan JJ, "Proposal for the 8th edition of the AJCC", UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy, 2016, pp.122, 546~558
  4. Chinese Committee for Staging of Nasopharyngeal Carcinoma, "Report on revision of the Chinese 1992 staging system for nasopharyngeal carcinoma", J Radiat Oncol, 2, pp.233~240 (2013)
  5. Caineng Cao, "Magnetic Resonance Imaging–Detected Intracranial Extension in the T4 Classification Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy", Cancer Research and Treatment, 49(2), pp.518~525 (2017), 대한암학회
  6. Chong VF, "Computed tomographic and magnetic resonance imaging findings in paranasal sinus involvement in nasopharyngeal carcinoma", Ann Acad Med Singapore, 27, pp.800~804 (1998)
  7. King AD, "MRI of local disease in nasopharyngeal carcinoma : tumour extent vs tumour stage", Br J Radiol, 72, pp.734~741 (1999)
  8. Tao CJ, "Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensitymodulated radiotherapy", Chin J Cancer, 32, pp.494~501 (2013)
  9. Tian L, "Nasopharyngeal carcinoma with paranasal sinus invasion : the prognostic significance and the evidence-based study basis of its T-staging category according to the AJCC staging system", BMC Cancer, 14, pp.832~ (2014)
  10. Zhang Y, "Should all nasopharyngeal carcinoma with paranasal sinus invasion be staged as T3 in the intensity-modulated radiotherapy era? A study of 1811 cases", J Cancer, 7, pp.1353~1359 (2016)
  11. Jin T, "Neoadjuvant chemotherapy with different dose regimens of docetaxel, cisplatin and fluorouracil(TPF)for locoregionally advanced nasopharyngeal carcinoma : a retrospective study", Oncotarget, 8, pp.100764~100772 (2017)
  12. Chung NN, "Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma : primary tumor target delineation for radiotherapy", Head Neck, 26, pp.241~246 (2004)
  13. Abdel Khalek Abdel Razek A, "MRI and CT of nasopharyngeal carcinoma", AJR Am J Roentgenol, 198, pp.11~18 (2012)
  14. Lee AW, "Treatment results for nasopharyngeal carcinoma in the modern era : the Hong Kong experience", Int J Radiat Oncol Biol Phys, 61, pp.1107~1116 (2005)
  15. Chua ML, "Nasopharyngeal carcinoma", Lancet, 387, pp.1012~1024 (2016)
  16. Sun X, "Long-term outcomes of intensity-modulated radiotherapy for 868patients with nasopharyngeal carcinoma : an analysis of survival and treatment toxicities", Radiother Oncol, 110, pp.398~403 (2014)
  17. Chen L, "Grading of MRI-detected skull-base invasion in nasopharyngeal carcinoma and its prognostic value", Head Neck, 33, pp.1309~1314 (2011)
  18. Cao CN, "Update report of T4 classification nasopharyngeal carcinoma after intensity-modulated radiotherapy : an analysis of survival and treatment toxicities", Oral Oncol, 51, pp.190~194 (2015)
  19. Lee AW, "Management of nasopharyngeal carcinoma : current practice and future perspective", J Clin Oncol, 33, pp.3356~3364 (2015)
  20. Shedd DP, "Cancer of the nasopharynx in Connecticut, 1935 through 1959", Cancer, 20, pp.508~511 (1967)

관련 논문AI추천

Magnetic Resonance Imaging–Detected Intracranial Extension in the T4 Classification Nasopharyngeal Carcinoma with Intensity-Modulated RadiotherapyCaineng Cao, Guozhen Xu, Jianping Xiao, Jingwei Luo, Junlin Yi, Li Gao, Suyan Li, Xiaodong Huang, Zhong Zhang대한암학회 · Cancer Research and Treatment2017 · 제49권 제2호Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated RadiotherapyCaineng Cao, Qiaoying Hu, Xiaozhong Chen, Yanru Feng대한암학회 · Cancer Research and Treatment2019 · 제51권 제3호Proposal of a Pretreatment Nomogram for Predicting Local Recurrence after Intensity-Modulated Radiation Therapy in T4 Nasopharyngeal Carcinoma: A Retrospective Review of 415 Chinese PatientsAi-Hua Lin, Guan-Qun Zhou, Jiang Hu, Jun Ma, Lei Chen, Lu-Lu Zhang, Wen-Fei Li, Ying Sun, Yi-Yang Li, Zhen-Yu Qi대한암학회 · Cancer Research and Treatment2018 · 제50권 제4호Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort StudyDi-Han Liu, Hai-Qiang Mai, Hao-Jun Xie, Jin-Jie Yan, Jun Ma, Lin-Quan Tang, Li-Ting Liu, Ming-Huang Hong, Qing-Nan Tang, Qiu-Yan Chen, Sai-Lan Liu, Shan-Shan Guo, Xiao-Yun Li, Xue-Song Sun, Yue-Feng Wen, Yu-Jing Liang대한암학회 · Cancer Research and Treatment2019 · 제51권 제4호Feasibility of Selective Neck Irradiation with Lower Elective Radiation Dose in Treating Nasopharynx Cancer Patients김태규, 남희림, 노재명, 안용찬, 오동렬, 이언주, 이혜빈, 조원경대한암학회 · Cancer Research and Treatment2019 · 제51권 제2호Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-upBoyu Chen, Chong Zhao, Fei Han, Huageng Huang, Jingjing Miao, Lin Wang, Manyi Zhu, Shaomin Huang, Weiwei Xiao, Weixiong Xia, Xiang Guo, Xiaowu Deng, Xiao Xiao, Xing Lv, Yanqun Xiang, Yinglin Peng, Yingshan Liang대한암학회 · Cancer Research and Treatment2022 · 제54권 제1호

이 간행물의 다른 논문 (39건)

S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial김봉석, 장대영, 라선영, 김기향, 강석윤, 이문희, 정현철, 정민규, 형우진, 이충근, 김효송, 정재호, 신동복, 정인경, 이경희, 노성훈pp. 1-11The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106)김진호, 노재명, 이종훈, 김성환, 최진화, 김연실, 김원택, 오영택, 강민규, 김진희, 조관호, 이창걸, 김지윤, 문성호, 조문준, 안용찬, 금기창, 우홍균, 오동률, 하보람, 계철승pp. 12-23Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma김명진, 최진영, 박미숙, 이진용, 한경화, 강창무, 정용은, 김혜진pp. 24-33The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy EraSi-Yang Wang, Dong-Mei Mai, Yu-Yun Du, Dong-Hua Luo, Hao-Yuan Mo, Wang-Jian Zhang, Wayne R. Lawrence, Ya-Nan Jin, Xiu-Yu Cai, Mei-Su Lipp. 34-42Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)손주혁, 정경해, 박연희, 이경훈, 김태용, 박인혜, 이수이, 임석아, 노정실, 박경화, 김지현, 심성훈, 이근석, 안진희, 김성배, 남병호, 김희준pp. 43-52